facebook
twitter
rss
account
search
search
 

Findings point to better cancer detection

July 23, 2009 at 12:28 PM   |   Comments

NEW YORK, July 23 (UPI) -- New York researchers report they have discovered gene fusion that may lead to improved prostate cancer diagnosis.

The group, from Presbyterian Hospital/Weill Cornell Medical Center, said the new gene fusion found highly expressed in a subset of prostate cancers could lead not only to more accurate cancer testing but to targets for drug therapy and other potential treatments.

The findings are published in the August issue of the journal Neoplasia.

"The prostate cancer gene fusions, and proteins they produce, are important because they serve as a cancer-specific marker," says Dr. Mark A. Rubin of Weill Cornell Medical College.

"Currently, PSA testing is the standard of care, yet it is not accurate enough to predict prostate cancer because many men may have an elevated PSA level but have benign conditions such as inflammation of the prostate."

© 2009 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Android phones to join iPhone in saying no to the police Android phones to join iPhone in saying no to the police
2
Latest Ebola outbreak spreading much faster than in the past Latest Ebola outbreak spreading much faster than in the past
3
Physicists teleport photon over 15 miles Physicists teleport photon over 15 miles
4
Shellfish-inspired waterproof glue could help repair ships Shellfish-inspired waterproof glue could help repair ships
5
Pennsylvania officials issue $4.15 million fine to fracking company Pennsylvania officials issue $4.15 million fine to fracking company
Trending News
Video
x
Feedback